Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
Abstract Dendritic cells (DCs) are crucial in cancer immunity, because they activate cytotoxic T cells by presenting tumor antigens. Recently, oncolytic virus therapy has been recognized as a systemic immune stimulator. We previously developed a telomerase-specific oncolytic adenovirus (OBP-301) and...
Saved in:
Main Authors: | Tomoko Ohtani, Shinji Kuroda, Nobuhiko Kanaya, Yoshihiko Kakiuchi, Kento Kumon, Masashi Hashimoto, Chiaki Yagi, Ryoma Sugimoto, Satoru Kikuchi, Shunsuke Kagawa, Hiroshi Tazawa, Yasuo Urata, Toshiyoshi Fujiwara |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-11-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-024-03849-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis
by: Marc Otero-Mateo, et al.
Published: (2025-03-01) -
Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
by: Joanna R. Wares, et al.
Published: (2015-07-01) -
OFFICIAL MEDICATIONS FOR ANTI-TUMOR GENE THERAPY
by: E. R. Nemtsova, et al.
Published: (2016-12-01) -
<i>In vitro</i> and <i>in vivo</i> tropism and biodistribution of recombinant simian adenovirus type 25
by: Irina V. Vavilova, et al.
Published: (2024-11-01) -
Improving systemic delivery of oncolytic virus by cellular carriers
by: Ziyi Peng, et al.
Published: (2024-12-01)